Which therapeutic interventions are most appropriate for a patient with acute decompensated heart failure? (Select all that apply.)

Choice A rationale Patients in acute decompensated heart failure (ADHF) often experience pulmonary congestion due to elevated left ventricular end-diastolic pressure. This fluid in the alveoli impairs gas exchange, leading to hypoxemia. Providing supplemental oxygen therapy increases the partial pressure of oxygen in the lungs, improving systemic oxygen delivery and reducing the work of breathing. This is a critical immediate intervention to stabilize the patient and prevent myocardial ischemia or respiratory failure during an acute exacerbation of heart failure. Choice B rationale Daily weight assessments are one of the most reliable methods for monitoring fluid status in heart failure patients. A weight gain of more than 2 to 3 pounds in a day or 5 pounds in a week typically indicates significant fluid retention rather than caloric gain. In ADHF, tracking weights helps the healthcare team evaluate the effectiveness of diuretic therapy. It provides objective data that guides the titration of medications to achieve an optimal dry weight and prevent further congestion. Choice C rationale Encouraging high-sodium foods is contraindicated in acute decompensated heart failure. Sodium causes the body to retain water through osmotic pressure, which increases intravascular volume and worsens pulmonary and peripheral edema. Patients in ADHF should follow a strictly low-sodium diet (often less than 2,000 mg/day) to help decrease fluid overload and reduce the workload on the failing heart. Suggesting high-sodium foods would directly contribute to the patient's physiological decline and exacerbate their symptoms. Choice D rationale Administering intravenous diuretics, such as furosemide, is a cornerstone of ADHF treatment. IV administration ensures rapid onset of action and avoids the issues of poor gut absorption often seen in patients with systemic fluid overload. Diuretics promote the excretion of excess sodium and water by the kidneys, which rapidly reduces preload and alleviates pulmonary congestion. This intervention is essential for improving cardiac efficiency and relieving the patient's acute shortness of breath and peripheral swelling. Choice E rationale Discontinuing all cardiac medications during an acute decompensated heart failure episode is dangerous and counterproductive. While certain medications like beta blockers might be temporarily held or reduced if the patient is in cardiogenic shock, other medications such as ACE inhibitors or anticoagulants are often crucial for long-term management and complication prevention. Abruptly stopping all medications can lead to rebound hypertension, increased systemic vascular resistance, and a further decline in cardiac output, significantly worsening the patient's clinical prognosis. Choice F rationale Administering beta blockers immediately in the acute phase of decompensated heart failure can be harmful. Beta blockers have negative inotropic effects, meaning they decrease the force of myocardial contraction. In a patient with an acute drop in cardiac output and fluid overload, further reducing the heart's pumping ability can precipitate a total circulatory collapse. These medications are usually started or resumed only after the patient is stable and the excess fluid volume has been successfully removed through diuresis. Choice G rationale Promoting bed rest during the initial phase of fluid overload is appropriate to decrease the metabolic demands on the failing heart. Physical activity increases the heart rate and the need for oxygenated blood, which a decompensated heart cannot provide effectively. By resting in a high-Fowler's position, the patient also benefits from reduced venous return to the heart and improved lung expansion, which helps alleviate dyspnea. Once the patient is hemodynamically stable, gradual activity can be reintroduced.